Select Page

Experts

ALL EXPERTS

Dr. Eva Polverino

Secretary

Dr. Eva Polverino specializes in the area of pulmonary diseases.

Languages : English

BIOGRAPHY

Dr. Eva Polverino is a pulmonologist expert in respiratory infections affiliated with the European Respiratory Society.

Articles

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomize...
American Medical Association

2015Importance In patients with severe community-acquired pneumonia, treatment failure is associated with excessive inflammatory response and worse outcomes. Corticosteroids may modulate cytokine release in these patients, but the benefit of this adjunctive therapy remains controversial.

Read Full Article

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
European Respiratory Journal

2013This phase II, randomised, double-blind, multicentre study (NCT00930982) investigated the safety and efficacy of ciprofloxacin dry powder for inhalation (DPI) in patients with non-cystic fibrosis bronchiectasis.

Read Full Article

Microbial aetiology of community-acquired pneumonia and its relation to severity
BMJ Journals Thorax

2011The distribution of the microbial aetiology and mortality of community-acquired pneumonia (CAP) was investigated in relation to the clinical setting and severity scores (pneumonia severity index (PSI) and confusion, blood urea nitrogen, respiratory rate, blood pressure, age (CURB-65).

Read Full Article

Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations
BMJ Journals Thorax

2011Since the first British Thoracic Society (BTS) recommendations published in 2002 and web update in 2004, data from several studies have confirmed previous findings suggesting that neither resting sea level oxygen saturations nor forced expiratory volume in 1 s (FEV1) reliably predict hypoxaemia or complications of air travel in passengers with respiratory disease. It is thus now clear that there is no reliable threshold in these variables to determine accurately the safety of air travel or need for in-flight oxygen in an individual patient. Nevertheless, the need for practical recommendations remains. The new guidance covers bronchiectasis, cancer, hyperventilation and dysfunctional breathing, obesity, pulmonary arteriovenous malformations and sinus and middle ear disease, and has expanded sections on infection and comorbidity with cardiac disease.

Read Full Article

Severe Community-Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission
Clinical Infectious Diseases

2009The recent Infectious Disease Society of America/American Thoracic Society guidelines for the management of community-acquired pneumonia (CAP) in adults defined a predictive rule to identify patients with severe CAP to determine the need for intensive care unit (ICU) admission. We clinically validated this rule.

Read Full Article

Contact

MORE INFORMATION

Area of Expertise

Internal Medicine

Medicine

Pulmonary Diseases

Pulmonary Diseases

Research

Vaccination

Vaccines

Affiliation

European Respiratory Society

Industry

Research

Medical/Dental Practice

Education/Learning

Education

University of Pisa : Medicine, Pulmonary Disease Residency Program

Share This